Leila Alland Abeona Therapeutics Inc. (ABEO) insider trading activity

Leila Alland is Director of ABEONA THERAPEUTICS INC.. Currently has a direct ownership of 154,366 shares of ABEO, which is worth approximately $907,672. The most recent transaction as insider was on Jan 31, 2025, when has been sold 36,101 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 154K

30.53% 3M change

114.82% 12M change

Total Value Held $907,672

Leila Alland Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 31 2025	BUY Grant, award, or other acquisition	-	36,101 Added 18.95%	154,366 Common Stock
Aug 26 2024	BUY Grant, award, or other acquisition	-	11,797 Added 9.07%	118,265 Common Stock
Jul 08 2024	BUY Grant, award, or other acquisition	-	23,611 Added 18.15%	106,468 Common Stock
May 16 2024	BUY Open market or private purchase	$51,810 $4.71 p/Share	11,000 Added 11.72%	82,857 Common Stock
Sep 27 2023	SELL Open market or private sale	$28,259 $3.9 p/Share	7,246 Reduced 9.16%	71,857 Common Stock
Jun 14 2023	BUY Grant, award, or other acquisition	$271,143 $4.62 p/Share	58,689 Added 42.59%	79,103 Common Stock
Sep 26 2022	BUY Grant, award, or other acquisition	-	13,400 Added 39.63%	20,414 Common Stock
May 25 2021	BUY Grant, award, or other acquisition	-	77,181 Added 50.0%	77,181 Common Stock

Also insider at

PMVP

PMV Pharmaceuticals, Inc. Healthcare

Chief Medical Officer

Leila Alland

Director

Cranbury, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABEO shares.

Notify only if

Value

Insider Trading

Get notified when an Abeona Therapeutics Inc. insider buys or sells ABEO shares.

Notify only if

Operation

Value

Type

News

Receive news related to ABEONA THERAPEUTICS INC.

Track Activities on ABEO

Account